Related Concept Videos
01:16Clot Retraction and Fibrinolysis
10.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
10.2K
01:30Venous Thrombosis I: Introduction
700
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
700
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.4K
01:29Venous Thrombosis III: Interprofessional Care
466
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
466
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
668
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
668
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
439
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
439
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Effects of pneumatic tube systems on next-generation viscoelastic coagulation test devices in septic patients and healthy individuals: Results of the randomized controlled VETaPT trial.
Scientific reports·2026
Same author
Predictors of Hematoma Expansion and Response to Andexanet in Patients With Intracerebral Hemorrhage: Secondary Analyses of the ANNEXA-I Randomized Clinical Trial.
Stroke·2026
Same author
Viscoelastic point-of-care testing for monitoring unfractionated heparin in critically ill patients: a prospective observational study comparing ClotPro® IN/HI-Test, aPTT and Anti-Xa activity.
BMC anesthesiology·2026
Same author
Predictors of Intracranial Hemorrhage Volume Expansion in Patients Receiving Factor Xa Inhibitors in ANNEXA-4: Time and Severity Matter Most.
Stroke (Hoboken, N.J.)·2026
Same author
Indefinite anticoagulation with reduced-intensity direct oral anticoagulants in patients with splanchnic vein thrombosis. An international practice survey.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2025
Same author
Quantitative targeted proteomics for occult cancer screening in patients with unprovoked venous thromboembolism: results from the prospective PLATO-VTE study.
Research and practice in thrombosis and haemostasis·2025
Related Experiment Video
Updated: Apr 5, 2026
07:09
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
12.1K
Small clots with large impact.
Jan Beyer-Westendorf1, Walter Ageno2
1UNIVERSITY HOSPITAL "CARL GUSTAV CARUS";
Blood
|August 22, 2015
Summary
Splanchnic vein thrombosis (SVT) can indicate hidden cancer. This study highlights SVT
Area of Science:
- Hematology
- Oncology
- Vascular Medicine
Background:
- Splanchnic vein thrombosis (SVT) is a condition affecting blood flow in abdominal veins.
- The association between SVT and underlying malignancy requires further investigation.
Purpose of the Study:
- To evaluate the significance of splanchnic vein thrombosis (SVT) as an indicator of occult (hidden) malignant disease.
- To determine the diagnostic yield of investigating for cancer in patients presenting with SVT.
Main Methods:
- Retrospective analysis of patients diagnosed with splanchnic vein thrombosis (SVT).
- Review of diagnostic workup for malignancy in these patients.
- Statistical analysis to assess the correlation between SVT and cancer detection.
Main Results:
- A significant proportion of patients with splanchnic vein thrombosis (SVT) were diagnosed with occult malignant disease.
- The diagnostic yield for malignancy varied depending on patient demographics and thrombosis characteristics.
Conclusions:
- Splanchnic vein thrombosis (SVT) serves as a relevant marker for occult malignant disease.
- Systematic oncological screening is warranted in patients presenting with SVT to improve early cancer detection and patient outcomes.